Skip to main navigation Skip to search Skip to main content

Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Meta-analysis of Randomized Noninferiority Trials

  • Trevor Joseph Royce
  • , Dong Hoon Lee
  • , Na Na Keum
  • , Nitipong Permpalung
  • , Calvin J. Chiew
  • , Sherise Epstein
  • , Kristen M. Pluchino
  • , Anthony V. D'Amico
  • Harvard University
  • Brigham and Women’s Hospital
  • Dana-Farber Cancer Institute
  • Beth Israel Deaconess Medical Center

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations

Abstract

Hypofractionated radiation therapy as compared with conventionally fractionated radiation therapy may be the preferred radiotherapeutic approach to the management of localized prostate cancer in men at minimal risk for sustaining late genitourinary toxicity.

Original languageEnglish
Pages (from-to)577-584
Number of pages8
JournalEuropean Urology Focus
Volume5
Issue number4
DOIs
StatePublished - Jul 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hypofractionation
  • Prostate cancer
  • Radiation

Fingerprint

Dive into the research topics of 'Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Meta-analysis of Randomized Noninferiority Trials'. Together they form a unique fingerprint.

Cite this